Disease | N. SNPs d | DSI v | DPI v | Chr | Position | Consequence | Alleles | Class | AFEXOME | AFGENOME | Score vda | EI vda | N. PMIDs | First Ref. | Last Ref. | ||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Cardiovascular Diseases
|
711 | 0.500 | 0.840 | 3 | 12351626 | missense variant | C/G | snv | 0.11 | 8.9E-02 | 0.060 | 0.833 | 6 | 2003 | 2015 | ||||
Coronary Arteriosclerosis
|
440 | 0.500 | 0.840 | 3 | 12351626 | missense variant | C/G | snv | 0.11 | 8.9E-02 | 0.060 | 1.000 | 6 | 2005 | 2012 | ||||
Diabetic Nephropathy
|
238 | 0.500 | 0.840 | 3 | 12351626 | missense variant | C/G | snv | 0.11 | 8.9E-02 | 0.060 | 0.667 | 6 | 2007 | 2012 | ||||
Impaired cognition
|
348 | 0.500 | 0.840 | 3 | 12351626 | missense variant | C/G | snv | 0.11 | 8.9E-02 | 0.060 | 1.000 | 6 | 2008 | 2019 | ||||
Chronic kidney disease stage 5
|
194 | 0.500 | 0.840 | 3 | 12351626 | missense variant | C/G | snv | 0.11 | 8.9E-02 | 0.050 | 1.000 | 5 | 2005 | 2016 | ||||
Crohn Disease
|
1147 | 0.500 | 0.840 | 3 | 12351626 | missense variant | C/G | snv | 0.11 | 8.9E-02 | 0.050 | 1.000 | 5 | 2008 | 2014 | ||||
Diabetic Retinopathy
|
213 | 0.500 | 0.840 | 3 | 12351626 | missense variant | C/G | snv | 0.11 | 8.9E-02 | 0.050 | 0.600 | 5 | 2005 | 2017 | ||||
Kidney Failure, Chronic
|
425 | 0.500 | 0.840 | 3 | 12351626 | missense variant | C/G | snv | 0.11 | 8.9E-02 | 0.050 | 1.000 | 5 | 2005 | 2016 | ||||
Myocardial Infarction
|
680 | 0.500 | 0.840 | 3 | 12351626 | missense variant | C/G | snv | 0.11 | 8.9E-02 | 0.050 | 0.600 | 5 | 2003 | 2015 | ||||
Colon Carcinoma
|
275 | 0.500 | 0.840 | 3 | 12351626 | missense variant | C/G | snv | 0.11 | 8.9E-02 | 0.040 | 0.750 | 4 | 2005 | 2017 | ||||
Impaired glucose tolerance
|
81 | 0.500 | 0.840 | 3 | 12351626 | missense variant | C/G | snv | 0.11 | 8.9E-02 | 0.040 | 1.000 | 4 | 2000 | 2012 | ||||
Inflammatory Bowel Diseases
|
605 | 0.500 | 0.840 | 3 | 12351626 | missense variant | C/G | snv | 0.11 | 8.9E-02 | 0.040 | 0.750 | 4 | 2008 | 2012 | ||||
Insulin resistance syndrome
|
15 | 0.500 | 0.840 | 3 | 12351626 | missense variant | C/G | snv | 0.11 | 8.9E-02 | 0.040 | 1.000 | 4 | 2001 | 2002 | ||||
Malignant tumor of colon
|
688 | 0.500 | 0.840 | 3 | 12351626 | missense variant | C/G | snv | 0.11 | 8.9E-02 | 0.040 | 0.750 | 4 | 2005 | 2017 | ||||
Mental deterioration
|
121 | 0.500 | 0.840 | 3 | 12351626 | missense variant | C/G | snv | 0.11 | 8.9E-02 | 0.040 | 1.000 | 4 | 2008 | 2019 | ||||
Arteriosclerosis
|
267 | 0.500 | 0.840 | 3 | 12351626 | missense variant | C/G | snv | 0.11 | 8.9E-02 | 0.030 | 1.000 | 3 | 2003 | 2014 | ||||
Atherosclerosis
|
281 | 0.500 | 0.840 | 3 | 12351626 | missense variant | C/G | snv | 0.11 | 8.9E-02 | 0.030 | 1.000 | 3 | 2003 | 2014 | ||||
Diabetes Mellitus, Insulin-Dependent
|
954 | 0.500 | 0.840 | 3 | 12351626 | missense variant | C/G | snv | 0.11 | 8.9E-02 | 0.030 | 1.000 | 3 | 2008 | 2008 | ||||
Ischemic stroke
|
704 | 0.500 | 0.840 | 3 | 12351626 | missense variant | C/G | snv | 0.11 | 8.9E-02 | 0.030 | 1.000 | 3 | 2007 | 2019 | ||||
Malignant neoplasm of prostate
|
1082 | 0.500 | 0.840 | 3 | 12351626 | missense variant | C/G | snv | 0.11 | 8.9E-02 | 0.030 | 0.667 | 3 | 2003 | 2015 | ||||
Pediatric Obesity
|
67 | 0.500 | 0.840 | 3 | 12351626 | missense variant | C/G | snv | 0.11 | 8.9E-02 | 0.030 | 1.000 | 3 | 2009 | 2018 | ||||
Prostate carcinoma
|
1168 | 0.500 | 0.840 | 3 | 12351626 | missense variant | C/G | snv | 0.11 | 8.9E-02 | 0.030 | 0.667 | 3 | 2003 | 2015 | ||||
Ulcerative Colitis
|
827 | 0.500 | 0.840 | 3 | 12351626 | missense variant | C/G | snv | 0.11 | 8.9E-02 | 0.030 | 0.667 | 3 | 2010 | 2014 | ||||
Acne
|
11 | 0.500 | 0.840 | 3 | 12351626 | missense variant | C/G | snv | 0.11 | 8.9E-02 | 0.020 | 1.000 | 2 | 2014 | 2018 | ||||
Acne Vulgaris
|
37 | 0.500 | 0.840 | 3 | 12351626 | missense variant | C/G | snv | 0.11 | 8.9E-02 | 0.020 | 1.000 | 2 | 2014 | 2018 |